imipramine has been researched along with Dermatitis, Contact, Photoallergic in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In in vivo phototoxicity testing, ultraviolet A irradiation from 3 to 6 h after oral administration of IMI (100 mg/kg) caused more potent phototoxic reactions compared with that from 0 to 3 h, and DMI yielded by metabolism of IMI would be associated with phototoxic reactions caused by orally-administered IMI." | 1.62 | An approach to evaluate metabolite-related phototoxicity with combined use of photochemical properties and skin deposition. ( Iyama, Y; Onoue, S; Sato, H; Seto, Y; Tonami, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seto, Y | 1 |
| Tonami, R | 1 |
| Iyama, Y | 1 |
| Sato, H | 1 |
| Onoue, S | 1 |
1 other study available for imipramine and Dermatitis, Contact, Photoallergic
| Article | Year |
|---|---|
An approach to evaluate metabolite-related phototoxicity with combined use of photochemical properties and skin deposition.
Topics: Administration, Oral; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Desipramine; Imipramine; Ox | 2021 |